Back
Catalyst Pharmaceuticals Vs. Avalo Therapeutics Industry Stock Comparison
Sell
42
CPRX
Catalyst Pharmaceuticals
Last Price:
15.12
Seasonality Move:
5.15%
Sell
39
AVTX
Avalo Therapeutics
Last Price:
11.54
Seasonality Move:
-5.29%
Sell
42
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $15.34. The Score for CPRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy, Sell or Hold?
- The current Avalo Therapeutics [AVTX] share price is $12.00. The Score for AVTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- AVTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $15.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
AVTX Stock Price Chart
What is Avalo Therapeutics's stock price today?
-
The Avalo Therapeutics share price today is $12.00
The current trend is moderately bearish and AVTX is experiencing selling pressure, which indicates risk of future bearish movement.
CPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 46.76 | Sell |
Chaikin Money Flow: | -1373778 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.35 - 16.25) | Sell |
Bollinger Bands (100): | (13.98 - 16.18) | Buy |
AVTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.96 | Buy |
Relative Strength Index (14 RSI): | 50.56 | Buy |
Chaikin Money Flow: | -101402 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.63 - 16.87) | Buy |
Bollinger Bands (100): | (3.74 - 14.18) | Buy |
CPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.62 | Sell |
20-day SMA: | 15.67 | Sell |
50-day SMA: | 15.32 | Buy |
200-day SMA: | 14.14 | Buy |
8-day EMA: | 15.57 | Sell |
20-day EMA: | 15.63 | Sell |
50-day EMA: | 15.44 | Sell |
200-day EMA: | 14.56 | Buy |
AVTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.58 | Sell |
20-day SMA: | 12.92 | Sell |
50-day SMA: | 8 | Buy |
200-day SMA: | 23.45 | Sell |
8-day EMA: | 14.12 | Sell |
20-day EMA: | 12.75 | Sell |
50-day EMA: | 10.5 | Buy |
200-day EMA: | 149.95 | Sell |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.
Avalo Therapeutics Earnings Growth & AVTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.00 per share.
Catalyst Pharmaceuticals Technical Analysis
Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avalo Therapeutics Technical Analysis
Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |